Clinical Trial Update: Study Evaluating the Tolerance of Conjugate Meningococcal C Vaccine in Infants [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating tolerance of a conjugate meningococcal C vaccine in infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Meningitis

Drugs mentioned

• Conjugate Meningococcal C Vaccine (conjugate meningococcal C vaccine)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Meningitis, Meningococcal | Phase 2 | Status: COMPLETED